Corcept Therapeutics
CORT
#1767
Rank
$12.19 B
Marketcap
$112.79
Share price
-1.85%
Change (1 day)
54.78%
Change (1 year)

Corcept Therapeutics (CORT) - P/B ratio

P/B ratio as of September 2026 : 18.8

According to Corcept Therapeutics 's latest financial reports the company has a price-to-book ratio of 15.6351.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Corcept Therapeutics - P/B ratio (from 2004 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-316.21-23.19%
2024-12-318.0922.43%
2023-12-316.6151.66%
2022-12-314.36-28.38%
2021-12-316.084.75%
2020-12-315.8155.51%
2019-12-313.73-32.97%
2018-12-315.57-48.39%
2017-12-3110.8-44.6%
2016-12-3119.5-34%
2015-12-3129.5-132.88%
2014-12-31-89.8-688.73%
2013-12-3115.3560.05%
2012-12-312.31-72.08%
2011-12-318.28-37.09%
2010-12-3113.267.34%
2009-12-317.86161.86%
2008-12-313.00-63.8%
2007-12-318.2966.66%
2006-12-314.9860.13%
2005-12-313.110.9%
2004-12-313.08
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.88-58.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.71-64.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.74-90.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
32.1 70.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
7.80-58.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
6.44-65.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-20.4-208.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-2.66-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
2.05-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA